Joint Formulary & PAD

Nitrazepam - Primary insomnia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
CD
SPC
Restrictions / Comments :
Important


 

 

Status 2

Green (see narrative)
Formulations :
  • Oral suspension
Associated Icons :
CD
SPC
Restrictions / Comments :
Important

Liquid formulations are expensive and should only be used  where significant swallowing difficulties or feeding tube

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Nitrazepam
Indication :
Primary insomnia
Group Name :
Keywords :
hypnotics
Brand Names Include :
Important Information :

Short term treatment of sleep disturbances (max of 2 to 4 weeks), considered severe or disabling or where insomnia is subjecting the individual to extreme distress.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Nitrazepam is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Primary insomnia.